- Massachusetts Bar
Partner at Clark+Elbing LLP
Michael J Belliveau exclusively focuses on the biotechnology and pharmaceutical fields. Dr Belliveau has over 20 years of patent prosecution experience. His practice combines his legal training with his scientific experience and knowledge to help identify commercially relevant solutions for biotech and pharma clients of all sizes.
Dr Belliveau advises clients pursuing inventions in various fields of biotechnology and pharmaceuticals, including gene, cell and mRNA therapies, cancer therapeutics and diagnostics, infectious disease therapeutics and molecular diagnostics.
As an experienced patent prosecutor, Dr Belliveau is adept at obtaining strong global patent protection that provides commercial advantages in the marketplace. Dr Belliveau represents numerous start-up biotechnology companies, utilising imaginative legal and technical approaches to help build a strong IP position from inception. Dr Belliveau also provides counselling on infringement and patent validity issues and post-issuance proceedings. Dr Belliveau has shepherded more than a dozen companies through their IPOs, working closely with securities counsel to ensure a smooth process. Additionally, Dr Belliveau has performed extensive IP due diligence analyses on behalf of venture firms for acquisition and investment purposes, as well as marketing and manufacturing clearances for biopharmaceutical products on behalf of several of his clients.
Dr Belliveau received his PhD in neurobiology from Harvard University.